Intra-aortic Balloon Pump Market
Intra-aortic Balloon Pump Market by Product Type (Intra-aortic Balloon Pump (IABP) Console, Intra-aortic Balloon Pump (IABP) Catheters, and Introducer Tray), by Indication (Coronary Artery Diseases (Unstable Angina, and Myocardial Infarction (NSTEMI)), and Chronic Heart Failure), by End User (Hospitals, Ambulatory Surgical Centers, Independent Catheterization Labs, and Other End User Verticals), and by Region - Global Market Report (2024 to 2034)
Analysis of Intra-aortic Balloon Pump Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Intra-aortic Balloon Pump Market Outlook (2024 to 2034)
The global intra-aortic balloon pump market size value was around US$ 382.6 million in 2019. As per the analysis of the global IABP market, the demand for intra-aortic balloon pumps is predicted to capture a CAGR of 2.6% from 2024 to 2034. In the current year, 2024, the global sales of intra-aortic balloon pumps are expected to garner a revenue of around US$ 437.6 million.
The demographic shift toward the aging population in many countries has resulted in an increase in the prevalence of cardiovascular problems, consequently creating a higher demand for IABP devices.
The need for efficient cardiac support systems, such as intra-aortic balloon pumps, surged during the pandemic due to a rise in cardiac complication cases, including heart failure and myocardial infarction. In response to the growing demand for different types of aorta counterpulsation devices available in the present market, IABP manufacturing industries are striving to improve patient outcomes and device performance. By the end of this forecast period, the global intra-aortic balloon pump industry is forecasted to be valued at US$ 563.5 million.
Intra-aortic Balloon Pump Market Trends and Analysis
The utility of intra-aortic balloon pumps (IABP) as a vital surgical aid has increased manifolds in the last few years with the ongoing developments in cardiac surgery methods. In line with this development, aortic balloon pump manufacturers are concentrating on matching their goods to changing medical procedures, particularly concerning less invasive procedures.
More patient comfort and simplicity of use are made possible by lightweight and portable solutions, which also help to improve patient care. So, the intra-aortic balloon pump market sizes have decreased considerably in the last few years in response to the growing demand for compact medical equipment by healthcare institutes.
|Estimated Market Value (2024E)
|US$ 437.6 million
|Forecasted Market Value (2034F)
|US$ 563.5 million
|Global Market Growth Rate (2024 to 2034)
|Intra-aortic Balloon Pump (IABP) Catheters Segment Growth Rate (2024 to 2034)
|Ambulatory Surgical Center Segment Growth Rate (2024 to 2034)
|North America Market Share (2024)
|East Asia Market Share (2024)
|Key Companies Profiled
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What Factors Have Accelerated the Global Intra-aortic Balloon Pump Market Growth?
“Development of Innovative Devices and Proliferation of Cardiac Care Facilities”
The demand for intra-aortic balloon pumps is on the rise due to the growth of cardiac care facilities, including ambulatory surgical centers and independent catheterization labs. Further expansion of cardiac healthcare institutions, particularly in emerging economies, is anticipated to boost the demand for IABP insertion and propel the market.
The development of innovative devices influenced by the need for dual-purpose equipment that can serve as left ventricular assist devices (LVADs) and intra-aortic balloon pumps is an emerging trend nowadays. IABP manufacturers are striving to develop more adaptable tools that can meet the demand for different types of heart complications.
|Regional Market CAGR (2024 to 2034)
Who is the Leading Intra-aortic Balloon Pump Producer in East Asia?
“China holds a Greater Market Share and is also Growing at a Faster Rate”
The intra-aortic balloon manufacturing industries in East Asian countries of China, Japan, and South Korea contribute roughly 17% of the global production. In Asian countries, the IABP nursing interventions progressed rapidly during the pandemic years, along with the dire need for technologies that can improve patient care and device management by allowing medical personnel to monitor remotely.
According to Fact.MR market predictions, in East Asia, the use of IABP in heart failure is expected to follow a CAGR of 3.4% between 2024 and 2034. China is the leading producer of intra-aortic balloon pumps, which is estimated to account for nearly 54.5% of the regional demand. Smaller intra-aortic balloon pumps are being produced more by Chinese manufacturers in response to higher demand for portable and compact medical products in the Asian markets.
China is anticipated to record a 3.5% CAGR for the advancement of its intra-aortic balloon pump industries from a valuation of US$ 40 million in 2024 to US$ 57 million by 2034. Meanwhile, Japan is expected to witness an annual growth rate of 3% and South Korea 3.2% in production of intra-aortic balloon pumps during this period.
Why is the United States Dominating the Global Intra-aortic Balloon Pump Market?
“Technological Breakthroughs in Medical Devices Puts the United States in Top Position”
Three countries in the region-Canada, Mexico, and the United States, constitute the intra-aortic balloon pump (IABP) market of North America, which is estimated to be valued at around US$ 176 million in 2024. The United States, with a market valuation of US$ 107 million in 2024, is the leading market in North America and holds almost 60.9% of the regional market.
There has been a significant rise in the population of old age people in the United States who suffer from heart disease. As a result, current market players in the United States are emphasizing the customization of intra-aortic balloon pumps to meet the unique requirements and difficulties senior citizens face. Moreover, IABP device makers in the United States have gained a reputation for customizing their products to meet the particular needs of heart transplant procedures.
Through the projected years, the sales of intra-aortic balloon pumps in the United States are poised to grow at a rate of 2.7%. By the end of this projection period, the United States intra-aortic balloon pump market size, in terms of value, is expected to reach up to US$ 140 million. On the other hand, Canada is poised to witness a higher CAGR of 2.9% during this period, which is expected to take the total valuation of the intra-aortic balloon pump industries up to US$ 75 million by 2034 end.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Which Type of Intra-aortic Balloon Pump Products Are Expected to Propel the Market?
“IABP Catheters are Gaining More Traction in Recent Years”
Intra-aortic balloon pump consoles that are used to improve rehabilitation and post-operative healing hold a sizable share of the total market sales at present. Based on the findings of the market survey, the sales of IABP consoles worldwide are estimated to generate a revenue of around US$ 104.2 million in 2024. Meanwhile, the introducer trays constitute the leading market segment with an estimated market valuation of US$ 266 million in 2024. Over the forecast years, these two segments are expected to witness year-on-year growth rates of 2.8% and 2.3%, respectively.
Intra-aortic balloon pump catheters that facilitate seamless patient ambulation are in greater demand these days due to the strengthening of healthcare facilities across all countries. As per the analysis of the market by Fact.MR, the IABP catheter segment, is expected to increase in size at a rate of 3.2% per year during the projected period. By following this higher growth, the net valuation of this market segment is expected to reach a valuation of US$ 136.7 million by 2034, growing from US$ 104.2 million in 2024.
Who are the Prominent End Users for Intra-aortic Balloon Pump Manufacturing Industries?
“Independent Catheterization Labs are Now Creating More Demand than Hospitals”
Independent catheterization labs create significant demand in the present market among the several end-use verticals for IABPs and ventricular assist devices. In 2024, this end-user segment is expected to provide a business opportunity of US$ 186.8 million, estimated to be around 42.7% of the total revenue share. Over the next ten years, the demand for intra-aortic balloon pumps from this segment is expected to surge at an annual growth rate of 2%.
Ambulatory surgical centers are creating more demand for percutaneous IABP instruments these days owing to a greater understanding among patients about the value of early patient movement in cardiac treatment. Based on the industry analysis report by Fact.MR, the demand for intra-aortic balloon pumps in ambulatory surgical centers is expected to grow at a rate of 3.2% through 2034. The report further predicts the net revenue generated by this segment to reach nearly US$ 121.5 million by 2034 increasing from US$ 89.1 million in 2024.
The global market for intra-aortic balloon pumps is gradually becoming competitive with the entry of medical device manufacturers in the cardiac healthcare sector in the last few years. Rising competition among medical device industries has led to rapid technical advancements, resulting in the creation of increasingly complex intra-aortic balloon pump systems. Leading market players are spending more money on research and development to add innovative features that enhance the functionality of their products and brand recognition as a whole.
- In December 2022, Johnson & Johnson Company acquired a technology-based company, Abiomed. It is an American company that makes intra-aortic balloon pumps. With this acquisition, Johnson & Johnson aims to strengthen its position in the worldwide market for intra-aortic balloon pumps.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Key Segments Covered by Intra-aortic Balloon Pump Industry Survey Report
By Product Type:
- Intra-aortic Balloon Pump (IABP) Console
- Intra-aortic Balloon Pump (IABP) Catheters
- Introducer Tray
- Coronary Artery Diseases
- Unstable Angina
- Myocardial Infarction (NSTEMI)
- Chronic Heart Failure
- Coronary Artery Diseases
By End User Verticals:
- Ambulatory Surgical Centers
- Independent Catheterization Labs
- Other End User Verticals
- North America
- Latin America
- East Asia
- South Asia & Oceania
- The Middle East & Africa (MEA)
- FAQs -
What was the Value of the Intra-aortic Balloon Pump Market in 2019?
The global intra-aortic balloon pump market was worth US$ 382.6 million in 2019.
What is the Sales Outlook for the Intra-aortic Balloon Pump in 2024?
The global intra-aortic balloon pump market is likely to be valued at US$ 437.6 million in 2024.
What is the Demand Forecast for the Intra-aortic Balloon Pump for the Decade?
The intra-aortic balloon pump market value is likely to reach US$ 563.5 million by the end of 2034.
What is the Predicted Growth Rate for the Intra-aortic Balloon Pump Market?
Adoption of intra-aortic balloon pumps is projected to rise at a CAGR of 2.6% through 2034.
At What Rate is the United States Intra-aortic Balloon Pump Market Predicted to Grow?
The United States intra-aortic balloon pump market is likely to register a CAGR of 2.7% through 2034.
What is the Growth Potential of the Independent Catheterization Labs in the Market?
Independent catheterization labs are predicted to capture a market share of 42.7% in 2024.